SCHEMBL3367320

SCHEMBL3367320

CC(C)Oc1ccc([N+]2CCN(c3ncnc4cc(OCCN5CCOCC5)ccc34)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 12/20 0.54
FLT3 P36888 4/20 0.49
CSF1R P07333 3/20 0.49
KIT P10721 3/20 0.49
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
ILK Q13418 1/20 0.43
AURKA O14965 1/20 0.42
SRC P12931 4/20 0.42
KDR P35968 3/20 0.42
FGFR1 P11362 2/20 0.42
GAK O14976 2/20 0.41
PLK4 O00444 1/20 0.40
EPHB6 O15197 1/20 0.40
STK10 O94804 1/20 0.40
EGFR P00533 1/20 0.40
NTRK1 P04629 1/20 0.40
LCK P06239 1/20 0.40
PDGFRA P16234 1/20 0.40
FLT1 P17948 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3365789 0.80 PDGFRB (0.81) PDGFRBFLT3CSF1RKITSRC
SCHEMBL3367321 0.77 PRKDC (0.53) PDGFRBILKAURKASRCFGFR1
SCHEMBL3364012 0.77 PDGFRB (0.81) PDGFRBFLT3CSF1RKITSRC
SCHEMBL13841371 0.74 NPC1 (0.57) MEN1KMT2AILKSRCKDR
SCHEMBL15630158 0.73 MEN1 (0.64) MEN1KMT2A
SCHEMBL13114412 0.72 PDGFRB (0.79) PDGFRBFLT3CSF1RKITSRC
SCHEMBL15483915 0.72 ILK (0.55) MEN1KMT2AILKAURKASRC
SCHEMBL4507750 0.72 KDM4E (0.61) MEN1KMT2AILKSRCKDR
SCHEMBL4690065 0.72 KDM4E (0.54) MEN1KMT2AILKSRCKDR
SCHEMBL27111277 0.71 PDGFRB (0.57) PDGFRBFLT3CSF1RKITSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309569-B1 N-aryl-{4-[7-(alkoxy)quinazolin-4-yl]piperazinyl}carboxamide derivatives as PDGFRs inhibitors MILLENNIUM PHARM INC (US) 2010-10-06 EP claimed
EP-1309569-B1 N-aryl-{4-[7-(alkoxy)quinazolin-4-yl]piperazinyl}carboxamide derivatives as PDGFRs inhibitors MILLENNIUM PHARM INC (US) 2010-10-06 EP disclosed